Bloch, M. H., Panza, K. E., Landeros-Weisenberger, A., & Leckman, J. F. (2009). Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic Disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 48(9), 884–893. https://doi.org/10.1097/chi.0b013e3181b26e9f 

Dion, Y., Annable, L., Sandor, P., & Chouinard, G. (2002). Risperidone in the treatment of Tourette syndrome: A double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 22(1), 31–39. https://doi.org/10.1097/00004714-200202000-00006 

Müller-Vahl, K. R., Szejko, N., Verdellen, C., Roessner, V., Hoekstra, P. J., Hartmann, A., & Cath, D. C. (2022). European clinical guidelines for Tourette syndrome and other tic disorders: Summary statement. European Child & Adolescent Psychiatry, 31(3), 377–382. https://doi.org/10.1007/s00787-021-01832-4 

Sallee, F., Kohegyi, E., Zhao, J., McQuade, R., Cox, K., Sanchez, R., van Beek, A., Nyilas, M., Carson, W., & Kurlan, R. (2017). Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette’s Disorder in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology, 27(9), 771–781. https://doi.org/10.1089/cap.2016.0026  

Roessner, V., Plessen, K. J., Rothenberger, A., Ludolph, A. G., Rizzo, R., Skov, L., Strand, G., Stern, J. S., Termine, C., & Hoekstra, P. J. (2011). European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. European Child & Adolescent Psychiatry, 20(4), 173–196. https://doi.org/10.1007/s00787-011-0163-7  

Roessner, V., Plessen, K. J., Rothenberger, A., Ludolph, A. G., Rizzo, R., Skov, L., … & Hoekstra, P. J. (2021). Efficacy of pharmacological treatment in obsessive-compulsive disorder comorbid with tic disorder: A systematic review and meta-analysis. European Child & Adolescent Psychiatry, 30(6), 847–860. https://doi.org/10.1007/s00787-020-01539-8 

Sallee, F. R., Kohegyi, E., Zhao, J., McQuade, R. D., Cox, K., Sanchez, R., … & Kurlan, R. (2017). Randomized, double-blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of Tourette’s disorder in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 27(5), 393–403. https://doi.org/10.1089/cap.2016.0146 

Sallee, F. R., Nesbitt, L., Jackson, C., Sine, L., & Sikich, L. (1997). Pimozide versus haloperidol in Tourette’s disorder: A pilot study. American Journal of Psychiatry, 154(8), 1057–1059. https://doi.org/10.1176/ajp.154.8.1057 

Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003). A placebo-controlled trial of risperidone in Tourette syndrome. Neurology, 60(7), 1130–1135. https://doi.org/10.1212/01.wnl.0000055434.39968.67 

Shapiro, A. K., Shapiro, E., Fulop, G., & Hubbard, M. (1978). Controlled study of haloperidol, pimozide, and placebo in Tourette’s syndrome. American Journal of Psychiatry, 135(5), 585–587. https://doi.org/10.1176/ajp.135.5.585  

Singer, H. S., Wendlandt, J., Krieger, M., & Giuliano, J. (1989). Haloperidol, pimozide, and placebo in Tourette syndrome: A double-blind, placebo-controlled study. Archives of General Psychiatry, 46(8), 722–726. https://doi.org/10.1001/archpsyc.1989.01810080052006